National Cancer Institute Is Model For Central Institutional Review Board – Draft Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's draft guidance on centralized IRB review suggests creating regional or nonregional cooperatives as an alternate model. The document also makes recommendations for centralized IRB written procedures.